Cardiac sarcoidosis with extensive and heterogeneous left ventricular FDG uptake in absence of guidelines indication for an implantable defibrillator: Ventricular tachycardia precipitated by immunosuppressive therapy, should we have done differently?
Pacing and Clinical Electrophysiology · 2024
DOI: 10.1111/pace.14965 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pacing and Clinical Electrophysiology, 2024. Verfasst von Emile Voisine und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Québec City, Québec, Canada. Hauptthemen laut MEDLINE: Sarcoidosis, Defibrillators, Implantable, Tachycardia, Ventricular, Fluorodeoxyglucose F18. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
A 40‐year‐old man, newly diagnosed with cardiac sarcoidosis (CS) presented with symptomatic ventricular tachycardia three days after starting steroid‐based immunosuppressive therapy (IT). There was no clear guideline indication for implantable cardioverter‐defibrillator (ICD) before the initiation of IT. Shortly after ICD implantation and the initiation of anti‐arrhythmic drugs, recurring ventricular arrhythmias required titration of the anti‐arrhythmic drug therapy. One‐year follow‐up assessment showed no significant arrhythmias and complete PET scan FDG uptake suppression. This case, along with recent publications, suggests transient pro‐arrhythmic effects of steroids in patients with CS, which are not appropriately addressed in the current guidelines. We believe ICD implantation should be considered in clinically manifest CS before initiating IT, particularly in cases with heterogeneous and/or extensive FDG uptake on PET scans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Institut Universitaire de Cardiologie et de Pneumologie de Québec, Laval University, Québec City, Québec, Canada.
- Department of Cardiology, Hôpital du Sacré-Cœur de Montréal, Montréal, Québec, Canada.
- Arrhythmia Service, Division of Cardiology, Department of Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
ORCID-Profile: Emile Voisine, Jonathan Beaudoin
Zitieren
APA
Voisine, E., Lemay, S., Beaudoin, J., Jacob, P., Philippon, F., Marchand, L., Vallée-Marcotte, B., Bernier, F., Laliberté, C., Fortin, S., Komlosy, M. È., Birnie, D. H., & Sénéchal, M. (2024). Cardiac sarcoidosis with extensive and heterogeneous left ventricular FDG uptake in absence of guidelines indication for an implantable defibrillator: Ventricular tachycardia precipitated by immunosuppressive therapy, should we have done differently?. Pacing and Clinical Electrophysiology. https://doi.org/10.1111/pace.14965
Vancouver
Voisine E, Lemay S, Beaudoin J, Jacob P, Philippon F, Marchand L, et al. Cardiac sarcoidosis with extensive and heterogeneous left ventricular FDG uptake in absence of guidelines indication for an implantable defibrillator: Ventricular tachycardia precipitated by immunosuppressive therapy, should we have done differently?. Pacing and Clinical Electrophysiology. 2024. doi:10.1111/pace.14965
BibTeX
@article{Voisine2024,
author = {Voisine, Emile and Lemay, Sylvain and Beaudoin, Jonathan and Jacob, Philippe and Philippon, François and Marchand, Laurie and Vallée-Marcotte, Bastien and Bernier, Florence and Laliberté, Claudine and Fortin, Sophie and Komlosy, Marie-Ève and Birnie, David H and Sénéchal, Mario},
title = {Cardiac sarcoidosis with extensive and heterogeneous left ventricular FDG uptake in absence of guidelines indication for an implantable defibrillator: Ventricular tachycardia precipitated by immunosuppressive therapy, should we have done differently?},
journal = {Pacing and Clinical Electrophysiology},
year = {2024},
doi = {10.1111/pace.14965}
}
EUVIMED